McHutchison JG - Search Results

1

Clinical trial: the efficacy and safety of oral PF-03491390, a pancaspase inhibitor - a randomized placebo-controlled study in patients with chronic hepatitis C.

Shiffman ML, Pockros P, McHutchison JG, Schiff ER, Morris M, Burgess G. Shiffman ML, et al. Among authors: mchutchison jg. Aliment Pharmacol Ther. 2010 May;31(9):969-78. doi: 10.1111/j.1365-2036.2010.04264.x. Epub 2010 Feb 16. Aliment Pharmacol Ther. 2010. PMID: 20163376 Clinical Trial.

2

Clinical trial: interferon alpha-2b continuous long-term therapy vs. repeated 24-week cycles for re-treating chronic hepatitis C.

McHutchison JG, Patel K, Schiff ER, Gitlin N, Mur RE, Everson GT, Carithers RL Jr, Davis GL, Marcellin P, Shiffman ML, Harvey J, Albrecht JK; International Hepatitis Interventional Therapy Group. McHutchison JG, et al. Aliment Pharmacol Ther. 2008 Mar 1;27(5):422-32. doi: 10.1111/j.1365-2036.2007.03590.x. Epub 2007 Dec 11. Aliment Pharmacol Ther. 2008. PMID: 18081733 Clinical Trial.

3

Oral IDN-6556, an antiapoptotic caspase inhibitor, may lower aminotransferase activity in patients with chronic hepatitis C.

Pockros PJ, Schiff ER, Shiffman ML, McHutchison JG, Gish RG, Afdhal NH, Makhviladze M, Huyghe M, Hecht D, Oltersdorf T, Shapiro DA. Pockros PJ, et al. Among authors: mchutchison jg. Hepatology. 2007 Aug;46(2):324-9. doi: 10.1002/hep.21664. Hepatology. 2007. PMID: 17654603 Clinical Trial.

4

Prednisone withdrawal followed by interferon alpha for treatment of chronic hepatitis C infection: results of a randomized controlled trial.

McHutchison JG, Ponnudurai R, Bylund DL, Anguiano A, Pockros PJ, Mondala T, Wilkes LB. McHutchison JG, et al. J Clin Gastroenterol. 2001 Feb;32(2):133-7. doi: 10.1097/00004836-200102000-00008. J Clin Gastroenterol. 2001. PMID: 11205648 Clinical Trial.

5

A randomized, double-blind, placebo-controlled dose-escalation trial of merimepodib (VX-497) and interferon-alpha in previously untreated patients with chronic hepatitis C.

McHutchison JG, Shiffman ML, Cheung RC, Gordon SC, Wright TL, Pottage JC Jr, McNair L, Ette E, Moseley S, Alam J. McHutchison JG, et al. Antivir Ther. 2005;10(5):635-43. Antivir Ther. 2005. PMID: 16152757 Clinical Trial.

6

Oral resiquimod in chronic HCV infection: safety and efficacy in 2 placebo-controlled, double-blind phase IIa studies.

Pockros PJ, Guyader D, Patton H, Tong MJ, Wright T, McHutchison JG, Meng TC. Pockros PJ, et al. Among authors: mchutchison jg. J Hepatol. 2007 Aug;47(2):174-82. doi: 10.1016/j.jhep.2007.02.025. Epub 2007 May 4. J Hepatol. 2007. PMID: 17532523 Clinical Trial.

7

Phase 1B, randomized, double-blind, dose-escalation trial of CPG 10101 in patients with chronic hepatitis C virus.

McHutchison JG, Bacon BR, Gordon SC, Lawitz E, Shiffman M, Afdhal NH, Jacobson IM, Muir A, Al-Adhami M, Morris ML, Lekstrom-Himes JA, Efler SM, Davis HL. McHutchison JG, et al. Hepatology. 2007 Nov;46(5):1341-9. doi: 10.1002/hep.21773. Hepatology. 2007. PMID: 17929306 Clinical Trial.

8

Albinterferon Alfa-2b was not inferior to pegylated interferon-α in a randomized trial of patients with chronic hepatitis C virus genotype 2 or 3.

Nelson DR, Benhamou Y, Chuang WL, Lawitz EJ, Rodriguez-Torres M, Flisiak R, Rasenack JW, Kryczka W, Lee CM, Bain VG, Pianko S, Patel K, Cronin PW, Pulkstenis E, Subramanian GM, McHutchison JG; ACHIEVE-2/3 Study Team. Nelson DR, et al. Among authors: mchutchison jg. Gastroenterology. 2010 Oct;139(4):1267-76. doi: 10.1053/j.gastro.2010.06.062. Epub 2010 Jul 1. Gastroenterology. 2010. PMID: 20600017 Free PMC article. Clinical Trial.

9

Safety and efficacy of ledipasvir-sofosbuvir in black patients with hepatitis C virus infection: A retrospective analysis of phase 3 data.

Wilder JM, Jeffers LJ, Ravendhran N, Shiffman ML, Poulos J, Sulkowski MS, Gitlin N, Workowski K, Zhu Y, Yang JC, Pang PS, McHutchison JG, Muir AJ, Howell C, Kowdley K, Afdhal N, Reddy KR. Wilder JM, et al. Among authors: mchutchison jg. Hepatology. 2016 Feb;63(2):437-44. doi: 10.1002/hep.28334. Epub 2015 Dec 18. Hepatology. 2016. PMID: 26547499 Free PMC article. Clinical Trial.

10

Interferon alfa-2b alone or in combination with ribavirin as initial treatment for chronic hepatitis C. Hepatitis Interventional Therapy Group.

McHutchison JG, Gordon SC, Schiff ER, Shiffman ML, Lee WM, Rustgi VK, Goodman ZD, Ling MH, Cort S, Albrecht JK. McHutchison JG, et al. N Engl J Med. 1998 Nov 19;339(21):1485-92. doi: 10.1056/NEJM199811193392101. N Engl J Med. 1998. PMID: 9819446 Free article. Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

394 results

Search Page

Filters